Aardvark Therapeutics, Inc. (AARD) Form 8-K — Jun 12, 2026
Aardvark Therapeutics, Inc. filed an 8-K reporting the execution of retention bonus agreements with its Chief Financial Officer and Chief Operating Officer, Nelson Sun, and its Chief Medical Officer, Manasi Jaiman. Nelson Sun is entitled to a total cash retention bonus of $346,500, comprising a $198,000 guaranteed annual bonus for 2026 and a $148,500 retention component, payable on January 1, 2027, subject to continued employment. Manasi Jaiman is entitled to a total cash retention bonus of $357,000, comprising a $204,000 guaranteed annual bonus for 2026 and a $153,000 retention component, also payable on January 1, 2027, subject to continued employment.
Key figures
- Sun retention component
- 148500
- Sun guaranteed bonus 2026
- 198000
- Sun retention bonus total
- 346500
- Jaiman retention component
- 153000
- Jaiman guaranteed bonus 2026
- 204000
- Jaiman retention bonus total
- 357000
Price after filing
Close on the filing date to close N calendar days later (from $3.64). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.